Jiangsu Aidea Pharmaceutical Co., Ltd. produces and sells human protein products, and carries out some generic drug business and distributes Abbott's HIV diagnostic equipment and reagents. The company operates through two segments: Formulated Products and Raw Materials. Its products include Folium Sennae Granules, Powdered Bacillus Tablets, Clindamycin Hydrochloride Capsules, Sodium Bicarbonate Tablets, Nitrendipine Tablets, Metronidazole Tablets, Compound Gentamycin Sulfate and Procaine Hydrochloride Sulfate Granules, Cefradine Capsules, Human Urinary Kallidinogenase, Crude Ulinastatin & Urokinase, High Purity Urokinase, Human Serum Albumin, Epidermal Growth Factor, Crude Human Epidermal Growth Factor, Beta-2 Microglobulin and Crude Beta-2 Microglobulin. Jiangsu Aidea Pharmaceutical was founded on December 15, 2009 and is headquartered in Yangzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company